Skip to content

Dynamic of the Acquisition of Antibiotic Resistance in Integrons in Neonatology Newborns

Dynamic of the Acquisition of Antibiotic Resistance in Integrons in Neonatology Newborns

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02434679
Acronym
DAIR3N
Enrollment
278
Registered
2015-05-05
Start date
2014-10-31
Completion date
2016-03-31
Last updated
2019-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacteriology

Keywords

antibiotics resistance integrons, neonatology newborns, digestive acquisition, dynamic of the acquisition of integrons

Brief summary

Antibiotic resistance is a major public health issue as multiresistant bacteria (MRB) are increasing. Among the actions to control resistance, one is an interesting lead: to prevent the emergence of resistant bacteria by limiting possibilities for bacteria to acquire resistance. Mechanisms of resistance genes acquisition are deeply studied but there are few data on the dynamic of acquisition over time. Among the genetic components that disseminate resistance genes, resistance integrons (RI) play a major role in the acquisition and dissemination of antibiotic resistance in gram-negative bacteria. The digestive tract of the newborn (NB), which is initially sterile, is colonized by a bacterial microbiota during the first days of life. It thus appears to be an appropriate model to study the dynamic of resistance acquisition. This project intends to follow the NB of neonatology over time in order to study the dynamic of the digestive acquisition of RI and MRB

Interventions

None listed

Sponsors

University Hospital, Limoges
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 1 Days
Healthy volunteers
No

Inclusion criteria

* Mother-child pairs that will be included in the study will be the pairs of all the NB, born in the center (in born) and hospitalized in the neonatology units of each center: with a predictable stay ≥ 3 weeks in the unit

Exclusion criteria

NB will not be included if: * They exhibit a birth defect, especially on the digestive tract * They are secondarily hospitalized after a postnatal transfer (out born). * The parents express their objection for the child to take part in the study * The stool sample of the mother has not been received

Design outcomes

Primary

MeasureTime frame
The occurrence over time of digestive acquisition of any type of RI3 weeks

Secondary

MeasureTime frameDescription
The occurrence over time of digestive acquisition of severals type of RI3 weeksintI1 whenever the gene encoding a class 1 integrase will be detected intI2 whenever the gene encoding a class 2 integrase will be detected intI3 whenever the gene encoding a class 3 integrase will be detected An association: intI1+intI2, intI1+intI3, intI2+intI3, intI1+intI2+intI3 will also be searched.
Occurrence over time of digestive acquisition of MRB in NB hospitalized in neonatology units3 weeksOccurrence over time of digestive acquisition of MRB in NB hospitalized in neonatology units

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026